Inside Drug Pricing

AstraZeneca Asks SCOTUS To Block IRA Drug Negotiation

By Luke Zarzecki / September 25, 2025 at 5:11 PM

AstraZeneca is petitioning the Supreme Court to block the Inflation Reduction Act (IRA) Medicare drug price negotiation program, arguing the IRA imposes on manufacturers’ constitutionally protected interests.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Inside Drug Pricing

AstraZeneca Asks SCOTUS To Block IRA Drug Negotiation

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.